drugset / Trial / NCT03872232
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administrated Rosuvastatin/Ezetimibe and Telmisartan in patients with primary hypercholesterolemia and essential hypertension.
Timeline
- Start
- 2019-02-26
- Primary completion
- 2020-08-12
- Completion
- 2020-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |
| Subject | Telmisartan | Other / unclassified | — | Oral |